Author

J. Philippou-Massier

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

H. Blum· 3 shared C. B. Mast· 2 shared C. L. Kufner· 2 shared D. B. Bucher· 2 shared D. Braun· 2 shared M. Fischaleck· 2 shared W. Zinth· 2 shared A. Zutz· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiophysics

H. Blum

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Selection of the Early Genetic Code by Ultraviolet Light

C. L. Kufner, S. B. Krebs, M. Fischaleck, J. Philippou-Massier, H. Blum, D. B. Bucher, D. Braun, W. Zinth, C. B. Mast

This study quantifies UV stability of DNA sequences and simulates photodamage to proto-genomes, showing UV compatibility of early life and ranking codon evolutionary models by UV resistance.

bioRxiv · Oct 13, 2022 · PreprintBiophysics

Sequence Dependent UV Damage of Complete Pools of Oligonucleotides

C. L. Kufner, S. Krebs, M. Fischaleck, J. Philippou-Massier, H. Blum, D. B. Bucher, D. Braun, W. Zinth, C. B. Mast

The paper quantifies UV damage susceptibility of all 4096 hexamer DNA sequences using high-throughput sequencing, revealing sequence context effects on lesion formation.

bioRxiv · Aug 1, 2022Biophysics

Histone deacetylase inhibitors butyrate and bufexamac inhibit de novo HIV-1 infection in CD4 T-cells

C. Schölz, L. Chen, A. Zutz, O. T. Keppler, J. Philippou-Massier, H. Blum, T. Liebner, C. Choudhary

This study shows that HDAC inhibitors butyrate and bufexamac inhibit de novo HIV-1 infection in CD4 T-cells without reactivating latent virus.

bioRxiv · Apr 29, 2020 · PreprintMicrobiology